LRP10 variants in progressive supranuclear palsy.

Neurobiology of Aging
Leonie J M VergouwFrank J de Jong

Abstract

The aim of this study was to explore whether variants in LRP10, recently associated with Parkinson's disease and dementia with Lewy bodies, are observed in 2 large cohorts (discovery and validation cohort) of patients with progressive supranuclear palsy (PSP). A total of 950 patients with PSP were enrolled: 246 patients with PSP (n = 85 possible (35%), n = 128 probable (52%), n = 33 definite (13%)) in the discovery cohort and 704 patients with definite PSP in the validation cohort. Sanger sequencing of all LRP10 exons and exon-intron boundaries was performed in the discovery cohort, and whole-exome sequencing was performed in the validation cohort. Two patients from the discovery cohort and 8 patients from the validation cohort carried a rare, heterozygous, and possibly pathogenic LRP10 variant (p.Gly326Asp, p.Asp389Asn, and p.Arg158His, p.Cys220Tyr, p.Thr278Ala, p.Gly306Asp, p.Glu486Asp, p.Arg554∗, p.Arg661Cys). In conclusion, possibly pathogenic LRP10 variants occur in a small fraction of patients with PSP and may be overrepresented in these patients compared with controls. This suggests that possibly pathogenic LRP10 variants may play a role in the development of PSP.

References

Sep 18, 1997·Acta Neuropathologica·N SuyamaK Imaoka
Sep 27, 2002·Annals of Neurology·Parvoneh PoorkajGerard D Schellenberg
Jul 6, 2004·Acta Neuropathologica·Omi Katsuse, Dennis W Dickson
Jan 18, 2006·Neuropathology and Applied Neurobiology·O A RossD W Dickson
Aug 22, 2007·Neurology·L Donker KaatJ C van Swieten
Jun 10, 2008·Lancet Neurology·Daniel G HealyUNKNOWN International LRRK2 Consortium
May 22, 2009·Neurology·L Donker KaatJ C van Swieten
Jun 21, 2011·Nature Genetics·Günter U HöglingerGerard D Schellenberg
Apr 25, 2012·Parkinsonism & Related Disorders·Sachiko UjiieNobutaka Hattori
Oct 2, 2013·Neuro-degenerative Diseases·Shinsuke FujiokaZbigniew K Wszolek
Dec 3, 2014·Parkinsonism & Related Disorders·Shinsuke FujiokaDennis W Dickson
Mar 5, 2016·American Journal of Human Genetics·Suzanne LesageUNKNOWN International Parkinson's Disease Genomics Consortium (IPDGC)
Oct 7, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Monica Sanchez-ContrerasRosa Rademakers
May 4, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Günter U HöglingerUNKNOWN Movement Disorder Society-endorsed PSP Study Group
Jun 12, 2018·Lancet Neurology·Marialuisa QuadriUNKNOWN International Parkinsonism Genetics Network
Dec 7, 2018·Lancet Neurology·Demis A KiaUNKNOWN International Parkinson's Disease Genomics Consortium
Dec 7, 2018·Lancet Neurology·Rita GuerreiroUNKNOWN International DLB Genetics Consortium
Dec 7, 2018·Lancet Neurology·Lasse PihlstrømUNKNOWN MSA Exome Consortium
May 31, 2019·Parkinsonism & Related Disorders·Leonie J M VergouwMarialuisa Quadri

❮ Previous
Next ❯

Citations

Jul 1, 2020·Journal of Alzheimer's Disease : JAD·Leonie J M VergouwVincenzo Bonifati
Jul 4, 2021·Parkinsonism & Related Disorders·Arianna ManiniAlessio Di Fonzo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.